Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain

NCT01701362 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

542

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuropathic Pain

Interventions

DRUG: pregabalin
DRUG: placebo

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.